Ignite Creation Date:
2025-12-26 @ 11:14 AM
Ignite Modification Date:
2025-12-29 @ 5:59 PM
Study NCT ID:
NCT05341128
Status:
COMPLETED
Last Update Posted:
2025-09-02
First Post:
2022-04-18
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Medical Records From Children With Central Precocious Puberty (CPP) in China
Sponsor:
Takeda
Organization:
Study Overview
Official Title:
Patient Characteristics, Treatment Patterns, and Resource Usage in Children Diagnosed With Central Precocious Puberty (CPP) in China
Status:
COMPLETED
Status Verified Date:
2025-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PACTURE
Brief Summary:
The main purpose is to describe how many children were treated during 24 months or less because of CPP and how treatment worked for them.
There are no participants in this trial, the study only involves reviewing participants medical past and current records and collecting information.
There are no participants in this trial, the study only involves reviewing participants medical past and current records and collecting information.
Detailed Description:
This is an observational, non-interventional, retrospective study to evaluate the participants characteristics, current treatment patterns and resource usage in Chinese pediatric participants diagnosed with CPP.
This study will enroll approximately 1000 participants.
The data available in an existing data source the Chinese CPP Big Data Platform database will be analyzed. All the participants will be assigned to a single observational cohort:
• Pediatric Participants With CPP
This multi-center trial will be conducted in China. The overall duration of the study will be approximately 3 years.
This study will enroll approximately 1000 participants.
The data available in an existing data source the Chinese CPP Big Data Platform database will be analyzed. All the participants will be assigned to a single observational cohort:
• Pediatric Participants With CPP
This multi-center trial will be conducted in China. The overall duration of the study will be approximately 3 years.
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: